Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Clinical Trials Awareness Week: Celebrating the impact of clinical research

By Andrew Powaleny  |    May 1, 2017
Today starts off the beginning of Clinical Trials Awareness Week, which shines a spotlight on how the clinical trials process helps deliver safe, effective medicines to patients.   Read More

Driving innovation through collaboration

By Emma Van Hook  |    April 17, 2017
A new report from Deloitte examines the changing landscape of biopharmaceutical research, as stakeholders across the R&D ecosystem are increasingly coming together to tackle sciences’ most vexing...   Read More

Guest Post: New threats could fundamentally alter innovation in drug manufacturing

By Guest Contributor  |    August 2, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

America’s biopharmaceutical industry is central to diverse R&D ecosystem

By Andrew Powaleny  |    March 29, 2016
America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that supports continued medical advances for patients. This includes small and large...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    March 18, 2016
ICYMI: Policy solutions for innovative treatment: Last week at our 2016 Annual Meeting, our president and CEO Steve Ubl discussed his vision for the organization and outlined policy solutions for...   Read More

New Video: Clinical trials serve as engine for local economic growth

By Priscilla VanderVeer  |    November 18, 2015
Without clinical trials, new medicines could not be approved and made available to the patients who need them. But beyond connecting patients to new treatments and potential cures for some of the...   Read More

New Report: Innovation in the Biopharmaceutical R&D Process – Adapting to a Changing Environment

By Anne McDonald Pritchett, PhD  |    June 30, 2015
With the average cost of developing, testing and receiving approval for a new medicine at $2.6 billion and rising, biopharmaceutical companies are continuously looking at new ways to increase...   Read More

Collaboration for Cures: Teaming Up to Advance Science and Save Lives

By Tina Stow  |    March 26, 2015
“Whether it’s our family, our friends, all of us are potentially patients one day.” In a single sentence, Dr. Anthony Coyle, senior vice president and chief scientific officer at Pfizer’s Centers...   Read More

Biopharmaceutical companies reaffirm commitment to patients in updated Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results

By Bill Chin, M.D.  |    December 10, 2014
Researchers in biopharmaceutical companies strive to discover and develop new medicines and vaccines that will help people to live longer, healthier lives.  They go to work every day knowing that...   Read More

Responsible Clinical Trial Data Sharing Is Enhancing Science and Improving Patient Health

By Josephine Martin  |    November 14, 2014
The discovery and development of new medicines for patients is a comprehensive, data-driven process that requires years of research. At the heart of this endeavor is the clinical trial, the rigorous...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates